Department of Otolaryngology and Communicative Sciences, University of Mississippi Medical Center, Jackson, MS.
Int Forum Allergy Rhinol. 2014 Feb;4(2):104-9. doi: 10.1002/alr.21256. Epub 2013 Dec 5.
The purpose of this study was to survey program directors of the accredited otolaryngology residency programs and resident attendees of the 2013 American Academy of Otolaryngic Allergy (AAOA) Basic/MOC Course regarding resident education and participation as well as assessment of competency in otolaryngic allergy and immunotherapy.
A multiple-choice questionnaire was sent to all accredited otolaryngology residency training programs in the United States as part of resident attendance at the 2013 AAOA CORE Basic/MOC Course. Following this, a similar multiple-choice survey was sent to all resident attendees from the programs that responded positively.
Program directors reported that 73% of their academic institutions offer allergy testing and immunotherapy. More PDs than residents indicated that residents participate in allergy practice and perform/interpret skin testing and in vitro testing, and more residents (85%) than program directors (63%) reported inadequate or no allergy training. Program directors and residents equally indicated that residents do not calculate immunotherapy vial formulations or administer immunotherapy injections. The majority of program directors indicated that resident competency in allergy was assessed through direct observation, whereas residents more commonly perceived that no assessment of competency was being performed for any portion of allergy practice.
This survey demonstrates a discrepancy between program directors and residents regarding resident involvement and adequacy of training in the allergy practice. Although the majority of otolaryngology residencies report offering otolaryngic allergy services and education, the vast majority of residents report inadequate allergy training and less participation in an allergy practice compared to the majority of program directors.
本研究旨在调查经认可的耳鼻喉科住院医师培训计划的项目主管以及 2013 年美国耳鼻喉过敏学院（AAOA）基础/维护职业能力课程的住院医师出席者，了解住院医师的教育和参与情况，以及评估耳鼻喉过敏和免疫治疗方面的能力。
向美国所有经认可的耳鼻喉科住院医师培训计划发送了一份多项选择题问卷，作为 2013 年 AAOA CORE 基础/维护职业能力课程住院医师出席的一部分。之后，向积极回复的计划中的所有住院医师出席者发送了类似的多项选择题调查。
项目主管报告称，其所在学术机构中有 73%提供过敏测试和免疫治疗。与住院医师相比，更多的项目主管表示住院医师参与过敏实践并进行/解读皮肤测试和体外测试，与项目主管（63%）相比，更多的住院医师（85%）报告称过敏培训不足或没有。项目主管和住院医师同样表示，住院医师不计算免疫治疗小瓶配方或进行免疫治疗注射。大多数项目主管表示，通过直接观察评估住院医师在过敏方面的能力，而住院医师更普遍地认为，过敏实践的任何部分都没有进行能力评估。
这项调查表明，项目主管和住院医师在住院医师参与度和过敏实践培训的充分性方面存在差异。尽管大多数耳鼻喉科住院医师培训计划报告提供耳鼻喉过敏服务和教育，但与大多数项目主管相比，绝大多数住院医师报告过敏培训不足，参与过敏实践的程度较低。
